Literature DB >> 1962448

Isolation and characterization of mutants of vaccinia virus with a modified 94-kDa inclusion protein.

A de Carlos1, E Paez.   

Abstract

We have characterized one of the most highly expressed genes of vaccinia virus, WR strain, in the wild type and in several spontaneous mutants isolated from persistently infected cells. This gene encodes the 94-kDa inclusion protein, which is the vaccinia virus counterpart of the 160-kDa A-type inclusion (ATI) protein of cowpox virus. The homology index between both genes is greater than 95%. A deletion of two consecutive adenylate residues is responsible for a frameshift mutation and premature translational termination in the vaccinia virus gene. In addition, several point mutations and small deletions occur in the 94K gene. The deduced protein contains 725 amino acids, and 4 of the 10 repeated motifs present in the carboxyl terminus of the cowpox virus 160-kDa protein are conserved. In several mutants independently isolated from untreated and interferon-treated persistently infected cells, the gene encodes a 40-kDa protein. In mutant 87-4, this truncated protein is due to the insertion of a cytidilate residue that produces a frameshift mutation and premature translational termination. The deduced protein contains 366 amino acids and has lost all the repetitions. Transcriptional analysis has shown that the steady-state levels of mRNAs in cells infected with the mutants or wild-type vaccinia virus are similar. However, the accumulation of this protein in cells infected with the mutants is reduced indicating some instability. In addition the mutated protein is not recognized by polyclonal antisera. Existence of tandemly repeated sequences at the carboxyl terminus of this family of inclusion proteins correlates with their antigenicity. These results indicate a high degree of mutability of the ATI gene and products, which apparently has no consequence on replication in vitro, but could have relevance to control of the infection by immune responses in animal hosts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1962448     DOI: 10.1016/0042-6822(91)90548-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Genome of horsepox virus.

Authors:  E R Tulman; G Delhon; C L Afonso; Z Lu; L Zsak; N T Sandybaev; U Z Kerembekova; V L Zaitsev; G F Kutish; D L Rock
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  The vaccinia virus 4c and A-type inclusion proteins are specific markers for the intracellular mature virus particle.

Authors:  D Ulaeto; D Grosenbach; D E Hruby
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

3.  Formation of orthopoxvirus cytoplasmic A-type inclusion bodies and embedding of virions are dynamic processes requiring microtubules.

Authors:  Amanda R Howard; Bernard Moss
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

4.  Identification of SNPs associated with variola virus virulence.

Authors:  Anne Gatewood Hoen; Shea N Gardner; Jason H Moore
Journal:  BioData Min       Date:  2013-02-14       Impact factor: 2.522

5.  Identification of the orthopoxvirus p4c gene, which encodes a structural protein that directs intracellular mature virus particles into A-type inclusions.

Authors:  Terry A McKelvey; Stanley C Andrews; Sara E Miller; Caroline A Ray; David J Pickup
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  PCR strategy for identification and differentiation of small pox and other orthopoxviruses.

Authors:  S L Ropp; Q Jin; J C Knight; R F Massung; J J Esposito
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

7.  Characterization of the gene encoding the A-type inclusion body protein of mousepox virus.

Authors:  N Osterrieder; H Meyer; M Pfeffer
Journal:  Virus Genes       Date:  1994-03       Impact factor: 2.332

8.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.